Higher ambient levels of air pollutants are associated with increased risk of venous thromboembolism (VTE), according to a ...

Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it will receive a US$10 million milestone payment by its partner Takeda (TSE:4502/NYSE:TAK). Takeda received a national ...

You should also invest in attending at least one or two events per year. The expectations and behavior of searchers are constantly evolving, which means algorithms are constantly changing to keep up.

Long-term exposure to air pollution poses an increased risk of blood clots in deep veins, which can result in serious ...

The FDA also accepted Sobi’s New Drug Application (NDA) for avatrombopag for oral suspension. Avatrombopag for oral suspension is a capsule where its granules are sprinkled onto a soft food or liquid ...

Adverse events associated with ponatinib in CML and ALL were shown to have decreased significantly since its approval, ...

LYNPARZA® (olaparib) Demonstrated Clinically Meaningful Prolonged Survival Benefit in Early Breast Cancer in OlympiA Phase 3 Trial ...

Lenalidomide improved upon the efficacy of durvalumab in patients with refractory or advanced CTCL in a phase 1/2 trial.

A recent study found that the prevalence of thromboembolic events is increased in individuals with Dermatomyositis with ...

A recent study highlights an increased risk of thromboembolic events in metastatic lung cancer patients treated with immune ...

Discover the heightened thromboembolic risk for metastatic lung cancer patients on immune checkpoint inhibitors. Learn about ...

Research on hormone therapy reveals critical insights into cardiovascular disease risks, guiding clinicians in selecting ...